Alzinova AB vs Oligomerix, Inc

Alzinova AB logo

Alzinova AB

Swedish clinical stage biopharma company developing disease-modifying treatments against Alzheimer's disease

10 employees · est. 2011 · Sweden

VS
Oligomerix, Inc logo

Oligomerix, Inc

Developing small molecule therapeutics targeting tau for rare neuro diseases and AD - clinical studies starting 2022

10 employees · est. 2006 · White Plains, United States

Oligomerix, Inc is the older company (2011 vs 2006).

Side-by-Side Comparison

Alzinova AB Oligomerix, Inc
Founded
2011 2006 older
Headquarters
Sweden White Plains, United States
Employees
10 10
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology
Funding Stage
Grant Grant
Total Funding
Not tracked yet $17.62M
Funding Rounds
Not tracked yet 8
Taxonomy
Not tracked yet Neurodegenerative DiseasesTau ProteinRare TauopathiesAlzheimer's DiseaseSmall Molecule TherapeuticsClinical Studies +7
Website
alzinova.com oligomerix.com
Alzinova AB logo

About Alzinova AB

Alzinova AB is a Swedish clinical-stage biopharma company developing treatments for Alzheimer’s disease by specifically targeting neurotoxic amyloid beta oligomers. The lead candidate, ALZ-101, is a therapeutic vaccine for the treatment of Alzheimer's. Alzinova’s proprietary AβCC peptide™ technology...

Oligomerix, Inc logo

About Oligomerix, Inc

Oligomerix, Inc is an emerging biotechnology company that is focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein, ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s dise...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Alzinova AB and Oligomerix, Inc for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Alzinova AB or Oligomerix, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Alzinova AB was founded in 2011, based in Sweden, with 10 employees. Alzinova AB is a Swedish clinical-stage biopharma company developing treatments for Alzheimer’s disease by specifically targeting neurotoxic amyloid beta oligomers. The lead candidate, ALZ-101, is a t. Oligomerix, Inc was founded in 2006, based in White Plains, United States, with 10 employees. Oligomerix, Inc is an emerging biotechnology company that is focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein, ranging from rar.
Alzinova AB has raised no disclosed funding and Oligomerix, Inc $17.62M. Latest stage: Alzinova AB Grant, Oligomerix, Inc Grant.
Both work in Biotechnology.

Compare Alzinova AB with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Oligomerix, Inc on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes